158 related articles for article (PubMed ID: 36929823)
1. The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge-Implications for Health Services Implementation.
Trubiano JA; Vogrin S; Mitri E; Hall R; Copaescu A; Waldron J; De Luca J; Rose M; Mackay G; Lambros B; Douglas AP; Holmes NE; Chua KYL
Clin Infect Dis; 2023 Jul; 77(1):19-22. PubMed ID: 36929823
[TBL] [Abstract][Full Text] [Related]
2. The Penicillin Allergy Delabeling Program: A Multicenter Whole-of-Hospital Health Services Intervention and Comparative Effectiveness Study.
Chua KYL; Vogrin S; Bury S; Douglas A; Holmes NE; Tan N; Brusco NK; Hall R; Lambros B; Lean J; Stevenson W; Devchand M; Garrett K; Thursky K; Grayson ML; Slavin MA; Phillips EJ; Trubiano JA
Clin Infect Dis; 2021 Aug; 73(3):487-496. PubMed ID: 32756983
[TBL] [Abstract][Full Text] [Related]
3. Characterizing Antibiotic Allergy Labels in a Large UK Hospital Population to Inform Antimicrobial Stewardship and Delabeling Assessment Strategy.
Jones NK; Morris B; Santos R; Nasser S; Gouliouris T
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2180-2189.e4. PubMed ID: 37088372
[TBL] [Abstract][Full Text] [Related]
4. Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study.
Trubiano JA; Vogrin S; Copaescu A; Nasra M; Douglas A; Holmes NE; Chua KYL
Allergy; 2022 Mar; 77(3):1038-1042. PubMed ID: 34735748
[No Abstract] [Full Text] [Related]
5. Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge.
Lim PPC; Moore LN; Minich NM; Wessell KR; Desai AP
Allergy Asthma Proc; 2024 Jan; 45(1):61-69. PubMed ID: 38151739
[No Abstract] [Full Text] [Related]
6. Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches.
Mitri E; Reynolds G; Hornung CJ; Trubiano JA
Expert Rev Anti Infect Ther; 2024; 22(1-3):59-69. PubMed ID: 38098185
[TBL] [Abstract][Full Text] [Related]
7. Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use.
Otani IM; Tang M; Wang L; Anstey KM; Hilts-Horeczko A; Li F; Le VP; Lee M; Bystritsky R; Mulliken JS; Wattier RL; Blumenthal KG; Doernberg SB
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2557-2567.e6. PubMed ID: 37182569
[TBL] [Abstract][Full Text] [Related]
8. Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling.
Olans RN; Olans RD
Clin Infect Dis; 2024 Jan; 78(1):227. PubMed ID: 37585654
[No Abstract] [Full Text] [Related]
9. The role of a clinical pharmacist in spurious Penicillin allergy: a narrative review.
Bhogal R; Hussain A; Balaji A; Bermingham WH; Marriott JF; Krishna MT
Int J Clin Pharm; 2021 Jun; 43(3):461-475. PubMed ID: 33439428
[TBL] [Abstract][Full Text] [Related]
10. Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy.
Kuruvilla M; Shih J; Patel K; Scanlon N
Allergy Asthma Proc; 2019 Jan; 40(1):57-61. PubMed ID: 30582497
[No Abstract] [Full Text] [Related]
11. Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations.
Anstey KM; Tsao L; Otani IM
Clin Rev Allergy Immunol; 2022 Jun; 62(3):484-504. PubMed ID: 35031956
[TBL] [Abstract][Full Text] [Related]
12. A novel 2-step process for the management of inpatient beta-lactam allergy labels.
Ravikumar R; Arora NS; Hanson R; Barhitte L; Nagel J; Aitken SL; Bashaw L; Gandhi T; Spranger E; Marshall VD; Eschenauer GA
Ann Allergy Asthma Immunol; 2024 Apr; 132(4):525-531.e1. PubMed ID: 38151095
[TBL] [Abstract][Full Text] [Related]
13. Matched Case-Control Study of the Long-Term Impact of Beta-Lactam Antibiotic Allergy Testing.
Trubiano JA; Marhoon N; Vogrin S; Chua KYL; Holmes NE
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988819
[TBL] [Abstract][Full Text] [Related]
14. Penicillin Allergy Delabeling: A Multidisciplinary Opportunity.
Staicu ML; Vyles D; Shenoy ES; Stone CA; Banks T; Alvarez KS; Blumenthal KG
J Allergy Clin Immunol Pract; 2020 Oct; 8(9):2858-2868.e16. PubMed ID: 33039010
[TBL] [Abstract][Full Text] [Related]
15. Penicillin allergy delabeling: Opportunities for implementation and dissemination.
Samarakoon U; Accarino J; Wurcel AG; Jaggers J; Judd A; Blumenthal KG
Ann Allergy Asthma Immunol; 2023 May; 130(5):554-564. PubMed ID: 36563744
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of patients labeled with a penicillin allergy to promote antimicrobial stewardship in dental practice.
Lockhart PB; Durkin MJ; Blumenthal KG; Paumier TM; Baddour LM
J Am Dent Assoc; 2024 Jul; 155(7):565-573.e1. PubMed ID: 38703160
[TBL] [Abstract][Full Text] [Related]
17. The challenge of de-labeling penicillin allergy.
Stone CA; Trubiano J; Coleman DT; Rukasin CRF; Phillips EJ
Allergy; 2020 Feb; 75(2):273-288. PubMed ID: 31049971
[TBL] [Abstract][Full Text] [Related]
18. Delabeling of Penicillin Allergy: Room for Improvement.
Fransson S; Damving CM; Boel JB; Arpi M; Skinhøj IG; Jarløv JO; Mosbech HF; Poulsen LK; Garvey LH
Int Arch Allergy Immunol; 2023; 184(9):870-874. PubMed ID: 37321191
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation.
Ham Y; Sukerman ES; Lewis JS; Tucker KJ; Yu DL; Joshi SR
Allergy Asthma Proc; 2021 Mar; 42(2):153-159. PubMed ID: 33685561
[No Abstract] [Full Text] [Related]
20. Penicillin Allergy Delabeling Program: an exploratory economic evaluation in the Australian context.
Brusco NK; Bury S; Chua KYL; Vogrin S; Holmes NE; Trubiano JA
Intern Med J; 2023 Jan; 53(1):74-83. PubMed ID: 34523209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
